alanine has been researched along with glucagon-like peptide 1 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Attoub, S; Casu, M; Conlon, JM; Flatt, PR; Mangoni, ML; Manzo, G; Rinaldi, AC; Scorciapino, MA; Srinivasan, D | 1 |
| Conlon, JM; Coquet, L; Jouenne, T; King, JD; Lampis, S; Lukic, ML; Mangoni, ML; McLaughlin, CM; Mechkarska, M; Scorciapino, MA | 1 |
| Adelhorst, K; Hedegaard, BB; Kirk, O; Knudsen, LB | 1 |
| Alberti, KG; Holst, JJ; Møller, J; Møller, N; Orskov, C; Orskov, L; Schmitz, O | 1 |
| Becher, T; El-Hag, O; Fischer, U; Freyse, EJ; Göke, B; Knospe, S | 1 |
| Cherrington, AD; Gustavson, SM; Moore, MC; Neal, DW; Nishizawa, M; Shiota, M; Snead, WL | 1 |
| Bailey, CJ; Flatt, PR; Gault, VA; Green, BD; Greer, B; Harriott, P; Irwin, N; Mooney, MH; O'Harte, FP | 1 |
| Flatt, PR; Gault, VA; Green, BD; Greer, B; Harriott, P; O'Harte, FP | 1 |
| Flatt, PR; Kelly, C; McClenaghan, NH; McCluskey, JT; Parke, HG | 1 |
| Chung, HS; Kim, YM; Lee, SM | 1 |
| Bosma, T; de Vries, L; de Vries, MP; Kuipers, A; Moll, GN; Rink, R | 1 |
| Abdel-Wahab, YHA; Casciaro, B; Conlon, JM; Flatt, PR; Mangoni, ML; Musale, V | 1 |
| Fairlie, DP; Fitzsimmons, RL; Hill, TA; Iyer, A; Lim, J; Loh, Z; Mitchell, J; Suen, JY; Wang, P; Xu, W | 1 |
| Dong, M; Jin, W; Yuan, S; Zhang, H | 1 |
1 trial(s) available for alanine and glucagon-like peptide 1
| Article | Year |
|---|---|
GLP-1 does not not acutely affect insulin sensitivity in healthy man.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Analysis of Variance; Blood Glucose; C-Peptide; Calorimetry, Indirect; Fatty Acids, Nonesterified; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Clamp Technique; Humans; Hydroxybutyrates; Infusions, Intravenous; Insulin; Insulin Secretion; Lactates; Male; Neurotransmitter Agents; Peptide Fragments; Reference Values; Somatostatin; Time Factors | 1996 |
13 other study(ies) available for alanine and glucagon-like peptide 1
| Article | Year |
|---|---|
Conformational Analysis of the Host-Defense Peptides Pseudhymenochirin-1Pb and -2Pa and Design of Analogues with Insulin-Releasing Activities and Reduced Toxicities.
Topics: Amino Acid Sequence; Amphibian Proteins; Animals; Antimicrobial Cationic Peptides; Cell Line, Tumor; Diabetes Mellitus, Type 2; Humans; Insulin; Insulin Secretion; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular | 2015 |
Purification, Conformational Analysis, and Properties of a Family of Tigerinin Peptides from Skin Secretions of the Crowned Bullfrog Hoplobatrachus occipitalis.
Topics: Amphibian Proteins; Animals; Antimicrobial Cationic Peptides; Diabetes Mellitus, Type 2; Humans; Hydrogen-Ion Concentration; Insulin; Interleukin-10; Interleukin-17; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Peptides; Rana catesbeiana; Skin | 2016 |
Structure-activity studies of glucagon-like peptide-1.
Topics: Adenylyl Cyclases; Alanine; Amino Acid Sequence; Animals; Binding, Competitive; Cell Line; Cell Membrane; Circular Dichroism; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Kinetics; Molecular Sequence Data; Peptide Fragments; Peptides; Protein Conformation; Protein Precursors; Receptors, Cell Surface; Receptors, Glucagon; Sequence Homology, Amino Acid; Structure-Activity Relationship | 1994 |
Blood glucose lowering and glucagonostatic effects of glucagon-like peptide I in insulin-deprived diabetic dogs.
Topics: Alanine; Animals; Blood Glucose; Diabetes Mellitus, Type 1; Dogs; Female; Glucagon; Glucagon-Like Peptide 1; Insulin; Male; Peptide Fragments; Protein Precursors; Urea | 1997 |
Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
Topics: Alanine; Animals; Blood Glucose; Cardiovascular System; Dogs; Fatty Acids, Nonesterified; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycerol; Glycogen; Hormones; Infusions, Intravenous; Lactic Acid; Liver; Liver Circulation; Osmolar Concentration; Peptide Fragments; Portal Vein; Protein Precursors | 2003 |
Degradation, receptor binding, insulin secreting and antihyperglycaemic actions of palmitate-derivatised native and Ala8-substituted GLP-1 analogues.
Topics: Alanine; Animals; Blood Glucose; Cell Line; Cricetinae; Cricetulus; Cyclic AMP; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Injections, Intraperitoneal; Insulin; Insulin Secretion; Islets of Langerhans; Lysine; Mice; Mice, Obese; Palmitates; Peptide Fragments; Protein Precursors; Radioligand Assay; Receptors, Glucagon; Valine | 2004 |
Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid.
Topics: Adenylyl Cyclases; Alanine; Aminobutyrates; Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclic AMP; Diabetes Mellitus; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Obese; Models, Chemical; Peptide Fragments; Peptides; Protein Precursors; Protein Structure, Tertiary; Spectrometry, Mass, Electrospray Ionization; Time Factors | 2004 |
The role of glucagon- and somatostatin-secreting cells in the regulation of insulin release and beta-cell function in heterotypic pseudoislets.
Topics: Alanine; Animals; Arginine; Cadherins; Cell Communication; Cell Proliferation; Cell Survival; Cells, Cultured; Connexin 43; Connexins; Gap Junction delta-2 Protein; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Somatostatin; Somatostatin-Secreting Cells | 2010 |
Novel AGLP-1 albumin fusion protein as a long-lasting agent for type 2 diabetes.
Topics: Alanine; Animals; Blood Glucose; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Glucagon-Like Peptide 1; Glucose Tolerance Test; Half-Life; Humans; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Rats; Recombinant Fusion Proteins; Serum Albumin; Transfection | 2013 |
Semi-microbiological synthesis of an active lysinoalanine-bridged analog of glucagon-like-peptide-1.
Topics: Alanine; Amino Acid Sequence; Bacterial Proteins; Glucagon-Like Peptide 1; Hydro-Lyases; Lactococcus lactis; Lysinoalanine; Membrane Proteins; Membrane Transport Proteins; Protein Processing, Post-Translational; SEC Translocation Channels; Serine; Substrate Specificity; Threonine | 2017 |
Assessment of the potential of temporin peptides from the frog Rana temporaria (Ranidae) as anti-diabetic agents.
Topics: Alanine; Amino Acid Sequence; Amphibian Proteins; Animals; Antimicrobial Cationic Peptides; Cell Proliferation; Glucagon-Like Peptide 1; Glucose; Humans; Hydrophobic and Hydrophilic Interactions; Hypoglycemic Agents; Injections, Intraperitoneal; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Protein Isoforms; Proteins; Rana temporaria; Rats; Skin | 2018 |
Modifying a Hydroxyl Patch in Glucagon-like Peptide 1 Produces Biased Agonists with Unique Signaling Profiles.
Topics: Alanine; Animals; beta-Arrestin 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Insulin; Mice; Signal Transduction | 2022 |
Oral glucagon-like peptide 1 analogue ameliorates glucose intolerance in db/db mice.
Topics: Alanine; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Glucagon-Like Peptide 1; Glucose Intolerance; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Serine | 2022 |